The Valley Desk

NCT03745287 · Interventional trial

A Safety and Efficacy Study Evaluating CTX001 in Subjects With Severe Sickle Cell Disease

Overall registry status Completed

Phase 2 · Phase 3

Conditions Hematological Diseases, Hemoglobinopathies, Sickle Cell Disease

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov